転移性乳癌:世界の臨床試験レビュー(2014年上半期)...市場調査レポートについてご紹介

【英文タイトル】Metastatic Breast Cancer Global Clinical Trials Review, H1, 2014

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Metastatic Breast Cancer 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Metastatic Breast Cancer to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Metastatic Breast Cancer to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Metastatic Breast Cancer 25
Subjects Recruited Over a Period of Time 43
Clinical Trials by Sponsor Type 44
Prominent Sponsors 45
Top Companies Participating in Metastatic Breast Cancer Therapeutics Clinical Trials 46
Prominent Drugs 48
Latest Clinical Trials News on Metastatic Breast Cancer 49
Feb 27, 2014: Eisai Announces Initiation of a Phase 3 Trial of Eribulin Mesylate Injection Versus Weekly Paclitaxel in First and Second Lines of Metastatic Breast Cancer 49
Jan 14, 2014: Etirinotecan Pegol Passes Interim Efficacy Analysis for BEACON Pivotal Phase 3 Clinical Study in Patients with Metastatic Breast Cancer 49
Oct 21, 2013: Seattle Genetics Initiates Phase 1 Trial of ADC Candidate, SGN-LIV1A, for Patients with LIV-1-Positive Metastatic Breast Cancer 50
Sep 03, 2013: Oncothyreon Announces Initiation of Phase 1 Trial of ONT-380 in Combination with Trastuzumab in Patients with Brain Metastases from HER2+ Breast Cancer 51
Jul 30, 2013: Nektar Completes Enrollment in Phase 3 BEACON Study of Etirinotecan Pegol in Women With Metastatic Breast Cancer 52
Clinical Trial Profiles 53
Clinical Trial Overview of Top Companies 53
F. Hoffmann-La Roche Ltd. 53
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 53
Novartis AG 67
Clinical Trial Overview of Novartis AG 67
GlaxoSmithKline plc 75
Clinical Trial Overview of GlaxoSmithKline plc 75
Eli Lilly and Company 81
Clinical Trial Overview of Eli Lilly and Company 81
AstraZeneca PLC 85
Clinical Trial Overview of AstraZeneca PLC 85
Pfizer Inc. 89
Clinical Trial Overview of Pfizer Inc. 89
Sanofi 93
Clinical Trial Overview of Sanofi 93
Bristol-Myers Squibb Company 97
Clinical Trial Overview of Bristol-Myers Squibb Company 97
Johnson & Johnson 101
Clinical Trial Overview of Johnson & Johnson 101
Celgene Corporation 103
Clinical Trial Overview of Celgene Corporation 103
Clinical Trial Overview of Top Institutes / Government 105
National Cancer Institute 105
Clinical Trial Overview of National Cancer Institute 105
The University of Texas M. D. Anderson Cancer Center 120
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 120
Memorial Sloan Kettering Cancer Center 124
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 124
Sarah Cannon Research Institute 126
Clinical Trial Overview of Sarah Cannon Research Institute 126
North Central Cancer Treatment Group 128
Clinical Trial Overview of North Central Cancer Treatment Group 128
European Organization for Research and Treatment of Cancer 130
Clinical Trial Overview of European Organization for Research and Treatment of Cancer 130
FUDAN University 132
Clinical Trial Overview of FUDAN University 132
UCLA’s Jonsson Comprehensive Cancer Center 134
Clinical Trial Overview of UCLA’s Jonsson Comprehensive Cancer Center 134
Vanderbilt-Ingram Cancer Center 135
Clinical Trial Overview of Vanderbilt-Ingram Cancer Center 135
Five Key Clinical Profiles 136
Appendix 206
Abbreviations 206
Definitions 206
Research Methodology 207
Secondary Research 207
About GlobalData 208
Contact Us 208
Disclaimer 208
Source 209


【レポート販売概要】

■ タイトル:転移性乳癌:世界の臨床試験レビュー(2014年上半期)
■ 英文:Metastatic Breast Cancer Global Clinical Trials Review, H1, 2014
■ 発行日:2014年3月31日
■ 調査会社:GlobalData
■ 商品コード:GDHC2056CTIDB
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。